Table 3.
Mar–Jun 2020 | Sep–Dec 2020 | Jan–May 2021 | 2020–2021 (total) | |
---|---|---|---|---|
Age group (years) | ||||
40–49 | 2.41 (1.39–4.20) | 1.98 (1.06–3.68) | 1.42 (0.79–2.56) | 1.48 (1.11–1.97) |
50–59 | 1.03 (0.79–1.35) | 1.29 (0.98–1.69) | 1.20 (0.94–1.53) | 1.15 (1.03–1.29) |
60–69 | 1.22 (1.08–1.37) | 1.43 (1.26–1.62) | 1.42 (1.27–1.59) | 1.28 (1.21–1.35) |
70–79 | 1.31 (1.19–1.44) | 1.55 (1.41–1.71) | 1.45 (1.33–1.58) | 1.31 (1.25–1.37) |
≥ 80 | 1.17 (1.08–1.26) | 1.34 (1.24–1.45) | 1.29 (1.21–1.38) | 1.20 (1.16–1.24) |
Sex | ||||
Men | 1.23 (1.15–1.31) | 1.47 (1.38–1.56) | 1.37 (1.29–1.45) | 1.25 (1.22–1.29) |
Women | 1.20 (1.09–1.32) | 1.31 (1.19–1.45) | 1.33 (1.23–1.44) | 1.23 (1.18–1.28) |
Total | 1.22 (1.15–1.28) | 1.42 (1.34–1.49) | 1.35 (1.29–1.42) | 1.24 (1.21–1.27) |
Relative risks (95% confidence intervals). AECOPD, acute exacerbation of chronic obstructive pulmonary disease.